December 17, 2013 (CARLSBAD, CA), AUDIT® MicroControls™ , Inc. is pleased to announce a new addition to our complete line of daily quality control products, the Control LQ Glycohemoglobin A1c. It is a liquid bi-level reference control consisting of human blood based solutions. It is intended to simulate human patient whole blood samples for the purpose of monitoring the precision of laboratory testing procedures for: Glycohemoglobin A1c. The Control LQ Glycohemoglobin A1c has been assayed for: Biorad Variant Turbo II, Ortho Vitros, Roche Integra, Siemens Dimension and Tosoh G7.


Packaged as 8 x 0.5 mL, this liquid product has an open vial stability of up to 50 days when stored at 2-8°C. (AUDIT MicroControls Item Number: K067M-8). AUDIT MicroControls provides a complete line of calibration verification/linearity and daily quality control products. Additionally, AUDIT offers laboratories Auditor™ QC, a free on-line, real time data reduction program that offers Levy-Jennings charts and peer group analysis for daily quality control product users, as well as linearity graphs and peer group analysis. Audit® FaxBack™ option allows the customer to fax their Cal Ver/Linearity data to AUDIT's Technical Solutions team with a turnaround time of approximately one business day.

AUDIT is the only total solution in daily quality controls and calibration verification materials for clinical laboratories. AUDIT provides value to customers through high-quality products, easy to use data management tools and unrivaled personalized service. Our partnership with Aalto Scientific, a leader in manufacture and supply for more than thirty years, enables us to offer significant cost savings to our customers. This synergistic partnership means our customers benefit from a broad line of superior solutions that address the challenges faced by today’s labs. By better understanding our customers’ needs, AUDIT can find ways to make life in the lab a little easier.


For more information about AUDIT, please call (866) 25-AUDIT or visit To connect via social media please visit,, and